https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/731689 Mon, 08 Jun 2026 12:00:00 -0400 https://www.bioworld.com/articles/731689-incyte-nabs-potential-vwd-game-changer-in-vega-deal-j-and-j-buys-firefly Collage of businesspeople http://www.bioworld.com/articles/731620 Thu, 04 Jun 2026 12:00:00 -0400 https://www.bioworld.com/articles/731620-ona-raises-866m-series-b-for-adcs-to-treat-advanced-cancers 3D dollar sign http://www.bioworld.com/articles/731644 Tue, 02 Jun 2026 12:00:00 -0400 https://www.bioworld.com/articles/731644-adcs-multispecific-antibodies-anchor-10b-pfizer-innovent-deal Antibodies attacking cancer cell http://www.bioworld.com/articles/731458 Fri, 29 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731458-adcs-multispecific-antibodies-anchor-10b-pfizer-innovent-deal Antibodies attacking cancer cell http://www.bioworld.com/articles/731455 Fri, 29 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731455-who-selects-vaccines-therapeutics-for-ebola-outbreak-field-trials Vials, syringes, pills and masks http://www.bioworld.com/articles/731418 Wed, 27 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731418-apogee-orbiting-big-ad-market-as-apex-phase-ii-data-land Close up dermatitis on the skin Pseudomonas aeruginosa and is now laying the ground for phase IIb development, after raising £4.3 million (US$5.8 million) in new capital.]]> http://www.bioworld.com/articles/731376 Thu, 21 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731376-infex-has-positive-phase-iia-data-in-bronchiectasis-preps-for-next-trial Lung infection caused by bacteria Pseudomonas aeruginosa http://www.bioworld.com/articles/731339 Wed, 20 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731339-immunovant-rises-on-imvt-1402-data-in-difficult-to-treat-ra Hands highlighted with joint pain http://www.bioworld.com/articles/731176 Wed, 20 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731176-re-aim-therapeutics-launches-with-focus-on-autoimmune-diseases Syringe, vial with pound currency symbol http://www.bioworld.com/articles/731139 Mon, 18 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731139-harbour-biomeds-let-003-shows-promise-for-obesity Illustration of monoclonal antibody hovering between doctor's hands http://www.bioworld.com/articles/731195 Thu, 14 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731195-biogen-ad-drug-shows-tau-cognition-benefit-despite-trial-miss Illustration of tau accumulating in a neuron cell. http://www.bioworld.com/articles/731224 Tue, 12 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731224-curacle-memento-ink-1b-deal-for-ocular-tie2-vegf-bispecific Eye, currency symbols and globe http://www.bioworld.com/articles/731193 Tue, 12 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/731193-curacle-memento-ink-1b-deal-for-ocular-tie2-vegf-bispecific Eye, currency symbols and globe http://www.bioworld.com/articles/731030 Mon, 11 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/731030-curacle-memento-ink-1b-deal-for-ocular-tie2-vegf-bispecific Eye, currency symbols and globe http://www.bioworld.com/articles/730998 Mon, 11 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/730998-singlomics-dxp-106-shows-robust-results-in-preclinical-setting http://www.bioworld.com/articles/730979 Fri, 08 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730979-budo-judo-moves-aplenty-for-climb-in-autoimmune Illustration of antibodies attacking nerve cells http://www.bioworld.com/articles/730970 Thu, 07 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730970-fda-slowdown-on-tzield-sbla-underlines-cnpv-questions FDA logo on textured paper Credit: Araki Illustrations - stock.adobe.com http://www.bioworld.com/articles/730861 Wed, 06 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730861-abdakibart-phase-ii-graded-puts-avalo-in-hs-upper-class Hand held near armpit http://www.bioworld.com/articles/730921 Tue, 05 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730921-how-to-summit-up-dis-harmoni-on-ivonescimab-nsclc-phase-iii Xray showing lung cancer on tablet http://www.bioworld.com/articles/730847 Tue, 05 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730847-viridians-reveal-2-beats-expectations-with-elegrobart-in-ted Eye with digital overlay http://www.bioworld.com/articles/730886 Tue, 05 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/730886-rct-1213-has-strong-activity-in-tm4sf5-expressing-tumors Art concept for monoclonal antibody cancer treatment http://www.bioworld.com/articles/730767 Fri, 01 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730767-how-to-summit-up-dis-harmoni-on-ivonescimab-nsclc-phase-iii Xray showing lung cancer on tablet http://www.bioworld.com/articles/730485 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730485-biogen-amasses-full-felzartamab-rights-with-850m-tj-deal Global handshake silhouette http://www.bioworld.com/articles/730427 Thu, 16 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730427-alethio-unveils-atx-011-for-essential-thrombocythemia 3D illustration of platelets in the boodstream http://www.bioworld.com/articles/730280 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730280-spyres-spy-001-induces-better-outcomes-in-ulcerative-colitis Ulcerative colitis http://www.bioworld.com/articles/730261 Fri, 10 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730261-invivyd-unveils-measles-monoclonal-antibody-candidate-vms-063 Photo of measles rash on skin http://www.bioworld.com/articles/730241 Thu, 09 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730241-ibios-ibio-600-cleared-to-enter-clinic-in-australia-for-obesity Tape measure, apple on scale http://www.bioworld.com/articles/730204 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730204-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute http://www.bioworld.com/articles/730094 Thu, 02 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730094-longhorn-reports-long-acting-peptidoglycan-targeted-mab-for-sepsis Illustration of monoclonal antibody hovering between doctor's hands http://www.bioworld.com/articles/729980 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729980-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute